Doctor Alexander Christian Falkentoft
Zealand University Hospital, Roskilde (Denmark)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Adherence and discontinuation of sglt2-inhibitors and glp1-r agonists in patients with type 2 diabetes with and without cardiovascular disease
Event: ESC Congress 2022
Topic: Antidiabetic Pharmacotherapy
Session: Anti-diabetic pharmacotherapy in clinical practice
The impact of statins and RAS inhibitors on the association between delayed antidiabetic treatment and the risk of cardiovascular event in patients with a first HbA1c between 48-57 mmol/mol
Event: ESC Congress 2022
Topic: Pharmacotherapy
Session: Diabetes and the heart 2
Socioeconomic position and initiation of SGLT-2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes - a Danish nationwide observational study
Event: ESC Congress 2021 - The Digital Experience
Topic: Diabetes and the Heart
Session: Risk Factors and Prevention ePosters
Socioeconomic position influences the risk of first-time cardiovascular event in patients with type 2 diabetes in spite of equal access to healthcare - a Danish nationwide cohort study
Event: ESC Congress 2020
Topic: Epidemiology
Session: Cardiovascular Involvement in pre-Diabetes
Copeptin - a marker of short- and long-term mortality in patients with ST-segment elevation myocardial infarction
Event: ESC Congress 2017
Topic: Biomarkers
Session: Adverse outcome in patients with cardiometabolic disorders
ESC 365 is supported by
